ZURICH/GDANSK, July 28 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Monday:
ROCHE ROG.S
Roche plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease symptoms, it said on Sunday, as a part of the company's growing development programme for the disease.
On Friday the U.S. Food and Drug Administration also said it was investigating the death of an eight-year-old boy who received Sarepta Therapeutics' SRPT.O muscular disorder gene therapy Elevidys, with partner Roche saying the death is unrelated to therapy.
ANALYSTS' VIEWS
LONZA GROUP AG LONN.S: JP MORGAN RAISES TARGET PRICE TO CHF 675 FROM CHF 650
ROCHE HOLDING AG ROG.S: JP MORGAN RAISES TARGET PRICE TO CHF 230 FROM CHF 220
ECONOMY
SNB sight deposits due at 0800 GMT.
(Reporting by Zurich newsroom and Gdansk newsroom)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS